NPI: 1790068542 · KENNEWICK, WA 99337 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/27/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 09/27/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,886 | $227K |
| 2019 | 9,696 | $371K |
| 2020 | 12,626 | $465K |
| 2021 | 13,729 | $581K |
| 2022 | 16,397 | $623K |
| 2023 | 11,764 | $320K |
| 2024 | 4,214 | $199K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| A4657 | Syringe, with or without needle, each | 5,529 | 1,532 | $1.41M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 27,265 | 1,843 | $1.31M |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 734 | 237 | $47K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 19,129 | 998 | $15K |
| J1756 | Injection, iron sucrose, 1 mg | 5,332 | 1,074 | $3K |
| 90670 | 16 | 16 | $516.80 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,889 | 727 | $200.00 |
| 85041 | 1,330 | 827 | $0.00 | |
| 83970 | 910 | 534 | $0.00 | |
| 85048 | 1,326 | 821 | $0.00 | |
| 83540 | 472 | 289 | $0.00 | |
| 82108 | 61 | 42 | $0.00 | |
| 83550 | 328 | 239 | $0.00 | |
| 82728 | 468 | 289 | $0.00 | |
| 82746 | 43 | 30 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 168 | 104 | $0.00 |
| 82607 | 43 | 30 | $0.00 | |
| 90674 | 17 | 12 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 80 | 45 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 160 | 70 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 12 | 12 | $0.00 |